Molecular cloning, expression, and initial characterization of members of the CYP3A family in horses

Drug Metabolism and Disposition

Volumn 38, Issue 10, 2010, Pages 1820-1827

  Knych, Heather K DiMaio ^a,b   McKemie, Daniel S ^a   Stanley, Scott D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; FELODIPINE; NIFEDIPINE; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CATALYSIS; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME KINETICS; GENE EXPRESSION; HORSE; IN VITRO STUDY; MASS SPECTROMETRY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN MODIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BACULOVIRIDAE; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; CYTOCHROME P-450 CYP3A; GENE EXPRESSION; HORSES; HUMANS; INSECTS; ISOENZYMES; KIDNEY; LIVER; MASS SPECTROMETRY; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; NIFEDIPINE; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TESTOSTERONE; VETERINARY DRUGS;

EQUIDAE;

EID: 77957162186     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.032953     Document Type: Article

References (14)

1. Carr B, Norcross R, Fang Y, Lu P, Rodrigues AD, Shou M, Rushmore T, and Booth-Genthe C (2006) Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes. Drug Metab Dispos 34:1703-1712. (Pubitemid 44427473)
2. Chauret N, Gauthier A, Martin J, and Nicoll-Griffith DA (1997) In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab Dispos 25:1130-1136. (Pubitemid 27446582)
3. Fraser DJ, Feyereisen R, Harlow GR, and Halpert JR (1997) Isolation, heterologous expression and functional characterization of a novel cytochrome P450 3A enzyme from a canine liver cDNA library. J Pharmacol Exp Ther 283:1425-1432. (Pubitemid 28016518)
4. Kitagawa K, Kunugita N, Kitagawa M, and Kawamoto T (2001) CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity. J Biol Chem 276:17830-17835.
5. Knych HK, DeStefano Shields C, Buckpitt AR, and Stanley SD (2009) Equine cytochrome P450 2C92: cDNA cloning, expression and initial characterization. Arch Biochem Biophys 485:49-55.
6. Knych HK and Stanley SD (2008) Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver. Biochem Pharmacol 76:904-911.
7. Koch I, Weil R, Wolbold R, Brockmöller J, Hustert E, Burk O, Nuessler A, Neuhaus P, Eichelbaum M, Zanger U, et al. (2002) Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab Dispos 30:1108-1114.
8. Kumar V, Rock DA, Warren CJ, Tracy TS, and Wahlstrom JL (2006) Enzyme source effects on CYP2C9 kinetics and inhibition. Drug Metab Dispos 34:1903-1908. (Pubitemid 44771720)
9. -ΔΔCT method. Methods 25:402-408.
10. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
11. Shimada T, Yamazaki H, Mimura M, Inui Y, and Guengerich FP (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414-423. (Pubitemid 24229655)
12. Tydén E, Olsén L, Tallkvist J, Larsson P, and Tjälve H (2004) CYP3A in horse intestines. Toxicol Appl Pharmacol 201:112-119.
13. Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, Hamman MA, Hall SD, and Wrighton SA (2002) Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metab Dispos 30:883-891. (Pubitemid 34815417)
14. Yuan R, Madani S, Wei XX, Reynolds K, and Huang SM (2002) Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab Dispos 30:1311-1319.